Gastric Cancer

Article	Citations
Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition)	187
Current status of immune checkpoint inhibitors for gastric cancer	121
Open versus minimally invasive total gastrectomy after neoadjuvant chemotherapy: results of a European randomized trial	73
Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial	72
Apatinib induced ferroptosis by lipid peroxidation in gastric cancer	69
Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial	62
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab	57
Phase I study of the recombinant humanized anti-HER2 monoclonal antibody–MMAE conjugate RC48-ADC in patients with HER2-positive advanced solid tumors	56
LncRNA HOTAIR promotes the growth and metastasis of gastric cancer by sponging miR-1277-5p and upregulating COL5A1	55
A nonrandomized, single-arm confirmatory trial of expanded endoscopic submucosal dissection indication for undifferentiated early gastric cancer: Japan Clinical Oncology Group study (JCOG1009/1010)	50
Endoscopic three-categorical diagnosis of Helicobacter pylori infection using linked color imaging and deep learning: a single-center prospective study (with video)	42
Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy	39
RP11-323N12.5 promotes the malignancy and immunosuppression of human gastric cancer by increasing YAP1 transcription	38
Epstein–Barr virus-encoded miR-BART5-5p upregulates PD-L1 through PIAS3/pSTAT3 modulation, worsening clinical outcomes of PD-L1-positive gastric carcinomas	36
Artificial intelligence-based diagnosis of upper gastrointestinal subepithelial lesions on endoscopic ultrasonography images	33
ASB16-AS1 up-regulated and phosphorylated TRIM37 to activate NF-κB pathway and promote proliferation, stemness, and cisplatin resistance of gastric cancer	33
Deep learning system for lymph node quantification and metastatic cancer identification from whole-slide pathology images	32
Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07	32
Impact of postoperative complications on survival outcomes in patients with gastric cancer: exploratory analysis of a randomized controlled JCOG1001 trial	31
Prognostic significance of sarcopenia in microsatellite-stable gastric cancer patients treated with programmed death-1 inhibitors	31
Multicenter prospective trial of total gastrectomy versus proximal gastrectomy for upper third cT1 gastric cancer	30
Cancer-associated fibroblasts-derived HAPLN1 promotes tumour invasion through extracellular matrix remodeling in gastric cancer	29
A deep learning method for delineating early gastric cancer resection margin under chromoendoscopy and white light endoscopy	29
Combined inhibition of PD-1/PD-L1, Lag-3, and Tim-3 axes augments antitumor immunity in gastric cancer–T cell coculture models	29
Landscape of EBV-positive gastric cancer	28

Multicenter phase III trial of S-1 and cisplatin versus S-1 and oxaliplatin combination chemotherapy for first-line treatment of advanced gastric cancer (SOPP trial)	27
Synchronous peritoneal metastases of gastric cancer origin: incidence, treatment and survival of a nationwide Dutch cohort	26
Phosphoproteomic analysis identifies CLK1 as a novel therapeutic target in gastric cancer	26
Epstein–Barr virus-associated gastric cancer: disease that requires special approach	25
Propionibacterium acnes overabundance in gastric cancer promote M2 polarization of macrophages via a TLR4/PI3K/Akt signaling	25
Uptake and tumor-suppressive pathways of exosome-associated GKN1 protein in gastric epithelial cells	24
Inhibiting the GAS6/AXL axis suppresses tumor progression by blocking the interaction between cancer-associated fibroblasts and cancer cells in gastric carcinoma	24
Mitochondrial GRIM-19 deficiency facilitates gastric cancer metastasis through oncogenic ROS-NRF2-HO-1 axis via a NRF2-HO-1 loop	24
Oral nutritional supplements versus a regular diet alone for body weight loss after gastrectomy: a phase 3, multicenter, open-label randomized controlled trial	24
Metabolomic profiling of gastric cancer tissues identified potential biomarkers for predicting peritoneal recurrence	23
Tumor mutation burden as a biomarker in resected gastric cancer via its association with immune infiltration and hypoxia	23
Discovery and development of trastuzumab deruxtecan and safety management for patients with HER2-positive gastric cancer	23
Hospital volume following major surgery for gastric cancer determines in-hospital mortality rate and failure to rescue: a nation-wide study based on German billing data (2009–2017)	23
Assessment of indocyanine green tracer-guided lymphadenectomy in laparoscopic gastrectomy after neoadjuvant chemotherapy for locally advanced gastric cancer: results from a multicenter analysis based	23
Assessment of diagnostic value of fluorescent lymphography-guided lymphadenectomy for gastric cancer	22
Involvement of non-Helicobacter pylori helicobacter infections in Helicobacter pylori-negative gastric MALT lymphoma pathogenesis and efficacy of eradication therapy	22
Apatinib exhibits synergistic effect with pyrotinib and reverses acquired pyrotinib resistance in HER2-positive gastric cancer via stem cell factor/c-kit signaling and its downstream pathways	22
Autophagy induced by Helicobacter pylori infection is necessary for gastric cancer stem cell emergence	22
Optimized PD-L1 scoring of gastric cancer	22
Identification of anti-Epstein-Barr virus (EBV) antibody signature in EBV-associated gastric carcinoma	21
Development and validation of a deep learning system for ascites cytopathology interpretation	21
Patient-reported outcomes from the phase II FAST trial of zolbetuximab plus EOX compared to EOX alone as first-line treatment of patients with metastatic CLDN18.2+ gastroesophageal adenocarcinoma	20
A novel genomic classification system of gastric cancer via integrating multidimensional genomic characteristics	20
Effect of Helicobacter pylori eradication after subtotal gastrectomy on the survival rate of patients with gastric cancer: follow-up for up to 15 years	20
Long-term persistence of gastric dysbiosis after eradication of Helicobacter pylori in patients who underwent endoscopic submucosal dissection for early gastric cancer	20
Immune suppression caused by PD-L2 expression on tumor cells in gastric cancer	20
Propranolol suppresses gastric cancer cell growth by regulating proliferation and apoptosis	19
Prognostic value of postoperative C-reactive protein elevation versus complication occurrence: a multicenter validation study	19
Association of surgeon and hospital volume with postoperative mortality after total gastrectomy for gastric cancer: data from 71,307 Japanese patients collected from a nationwide web-based data entry	19
Trastuzumab deruxtecan for the treatment of HER2-positive advanced gastric cancer: a clinical perspective	19
Establishment of oxaliplatin-resistant gastric cancer organoids: importance of myoferlin in the acquisition of oxaliplatin resistance	19
Comparison between endoscopic submucosal resection and surgery for the curative resection of undifferentiated-type early gastric cancer within expanded indications: a nationwide multi-center study	19
CAF promotes chemoresistance through NRP2 in gastric cancer	19
Cathepsin L promotes angiogenesis by regulating the CDP/Cux/VEGF-D pathway in human gastric cancer	18
Influence of anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissection: a multicenter retrospective study	18
The first case of gastric carcinoma with NTRK rearrangement: identification of a novel ATP1B–NTRK1 fusion	18
Hypoxia associated lncRNA HYPAL promotes proliferation of gastric cancer as ceRNA by sponging miR-431-5p to upregulate CDK14	18
Safe implementation of robotic gastrectomy for gastric cancer under the requirements for universal health insurance coverage: a retrospective cohort study using a nationwide registry database in Japan	18
Resistance to FGFR1-targeted therapy leads to autophagy via TAK1/AMPK activation in gastric cancer	17
EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein–Barr virus-associated gastric cancer	17
Enhanced tumor response to radiotherapy after PD-1 blockade in metastatic gastric cancer	17
Selective sensitivity of EZH2 inhibitors based on synthetic lethality in ARID1A-deficient gastric cancer	17
A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer	17
Promising aberrant DNA methylation marker to predict gastric cancer development in individuals with family history and long-term effects of H. pylori eradication on DNA methylation	17
Clinical significance of endoscopic ultrasonography in diagnosing invasion depth of early gastric cancer prior to endoscopic submucosal dissection	16
A panel of intestinal differentiation markers (CDX2, GPA33, and LI-cadherin) identifies gastric cancer patients with favourable prognosis	16
Real-world effectiveness of nivolumab in advanced gastric cancer: the DELIVER trial (JACCRO GC-08)	16
A novel combination of serum microRNAs for the detection of early gastric cancer	16
EPRS/GluRS promotes gastric cancer development via WNT/GSK-3β/β-catenin signaling pathway	16
WEE1 inhibition reverses trastuzumab resistance in HER2-positive cancers	16

Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study	16
Surgically treated gastric cancer in Japan: 2011 annual report of the national clinical database gastric cancer registry	15
Sex-specific prognostic effect of CD66b-positive tumor-infiltrating neutrophils (TANs) in gastric and esophageal adenocarcinoma	15
LRRC8A influences the growth of gastric cancer cells via the p53 signaling pathway	15
Interdisciplinary insights into the link between gut microbiome and gastric carcinogenesis—what is currently known?	15
Sex differences in tumor characteristics, treatment, and outcomes of gastric and esophageal cancer surgery: nationwide cohort data from the Dutch Upper GI Cancer Audit	15
Crosstalk between WNT and STAT3 is mediated by galectin-3 in tumor progression	15
Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer	15
Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS	15
Brain metastases in patients with upper gastrointestinal cancer is associated with proximally located adenocarcinoma and lymph node metastases	14
Postoperative complications after a transthoracic esophagectomy or a transhiatal gastrectomy in patients with esophagogastric junctional cancers: a prospective nationwide multicenter study	14
Different effects of p53 protein overexpression on the survival of gastric cancer patients according to Lauren histologic classification: a retrospective study	14
Preoperative risk factors for postoperative intra-abdominal infectious complication after gastrectomy for gastric cancer using a Japanese web-based nationwide database	14
The beginning of the era of precision medicine for gastric cancer with fibroblast growth factor receptor 2 aberration	14
Impact of preoperative chemotherapy as initial treatment for advanced gastric cancer with peritoneal metastasis limited to positive peritoneal lavage cytology (CY1) or localized peritoneal metastasis	14
Convergent dysbiosis of gastric mucosa and fluid microbiome during stomach carcinogenesis	14
Interleukin-17A derived from mast cells contributes to fibrosis in gastric cancer with peritoneal dissemination	14
Crosstalk between cancer-associated fibroblasts and immune cells in peritoneal metastasis: inhibition in the migration of M2 macrophages and mast cells by Tranilast	14
HDAC6/HNF4α loop mediated by miR-1 promotes bile acids-induced gastric intestinal metaplasia	14
Lysosomal-associated membrane protein family member 5 promotes the metastatic potential of gastric cancer cells	14
Inhibition of EZH2 and activation of ERRγ synergistically suppresses gastric cancer by inhibiting FOXM1 signaling pathway	14
Intracellular MUC20 variant 2 maintains mitochondrial calcium homeostasis and enhances drug resistance in gastric cancer	14
The incidences of metachronous multiple gastric cancer after various types of gastrectomy: analysis of data from a nationwide Japanese survey	13
Integrin β1 orchestrates the abnormal cell-matrix attachment and invasive behaviour of E-cadherin dysfunctional cells	13
Gastric cancer is highly prevalent in Lynch syndrome patients with atrophic gastritis	13
SHARPIN stabilizes β-catenin through a linear ubiquitination-independent manner to support gastric tumorigenesis	13
Histological diversity and molecular characteristics in gastric cancer: relation of cancer stem cell-related molecules and receptor tyrosine kinase molecules to mixed histological type and more histol	13
Indolent feature of Helicobacter pylori-uninfected intramucosal signet ring cell carcinomas with CDH1 mutations	13
SFRP4 drives invasion in gastric cancer and is an early predictor of recurrence	12
Mucin expression in gastric- and gastro-oesophageal signet-ring cell cancer: results from a comprehensive literature review and a large cohort study of Caucasian and Asian gastric cancer	12
Gastric equivalent of the ‘Holy Plane’ to standardize the surgical concept of stomach cancer to mesogastric excision: updating Jamieson and Dobson’s historic schema	12
Characteristic endoscopic findings of gastric adenocarcinoma of fundic-gland mucosa type	12
Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trial	12
Tumorigenic mechanisms of estrogen and Helicobacter pylori cytotoxin-associated gene A in estrogen receptor α-positive diffuse-type gastric adenocarcinoma	12
Expression of the immune checkpoint molecule V-set immunoglobulin domain-containing 4 is associated with poor prognosis in patients with advanced gastric cancer	12
A retrospective 5-year survival analysis of surgically resected gastric cancer cases from the Japanese Gastric Cancer Association nationwide registry (2001–2013)	12
Tumor mutation burden is correlated with response and prognosis in microsatellite-stable (MSS) gastric cancer patients undergoing neoadjuvant chemotherapy	11
CircTMC5 promotes gastric cancer progression and metastasis by targeting miR-361-3p/RABL6	11
Preservation of hepatic branch of the vagus nerve reduces the risk of gallstone formation after gastrectomy	11
Insulin and the insulin receptor collaborate to promote human gastric cancer	11
Pertuzumab, trastuzumab, and chemotherapy in HER2-positive gastric/gastroesophageal junction cancer: end-of-study analysis of the JACOB phase III randomized clinical trial	11
Nationwide cohort study: cholesterol level is inversely related with the risk of gastric cancer among postmenopausal women	11
Proteomics signature of autoimmune atrophic gastritis: towards a link with gastric cancer	10
Expression of CD44 variant 9 induces chemoresistance of gastric cancer by controlling intracellular reactive oxygen spices accumulation	10
Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trials	10
Trends in clinical outcomes and long-term survival after robotic gastrectomy for gastric cancer: a single high-volume center experience of consecutive 2000 patients	10
Multi-institutional development and validation of a nomogram to predict recurrence after curative resection of gastric neuroendocrine/mixed adenoneuroendocrine carcinoma	10
Optimal extent of lymph node dissection for remnant advanced gastric carcinoma after distal gastrectomy: a retrospective analysis of more than 3000 patients from the nationwide registry of the Japanes	10
Phase II study of S-1 and oxaliplatin as neoadjuvant chemotherapy for locally advanced adenocarcinoma of the gastric or esophagogastric junction: KSCC1601	10
Metformin use reduced the risk of stomach cancer in diabetic patients in Korea: an analysis of Korean NHIS-HEALS database	10
Uc.63+ contributes to gastric cancer progression through regulation of NF-kB signaling	10
Long-term adjuvant therapy for high-risk gastrointestinal stromal tumors in the real world	10
The expression of the alpha1 subunit of Na+/K+-ATPase is related to tumor development and clinical outcomes in gastric cancer	9
Risk factors of lymph node metastasis after non-curative endoscopic resection of undifferentiated-type early gastric cancer	9
Development and evaluation of a double-check support system using artificial intelligence in endoscopic screening for gastric cancer	9
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study	9
Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: where do we stand?	9
A multicenter phase II study of TAS-114 in combination with S-1 in patients with pretreated advanced gastric cancer (EPOC1604)	9
miRNAs derived from plasma small extracellular vesicles predict organo-tropic metastasis of gastric cancer	9
Treatment response after palliative radiotherapy for bleeding gastric cancer: a multicenter prospective observational study (JROSG 17-3)	9
Performance evaluation of four prediction models for risk stratification in gastric cancer screening among a high-risk population in China	9
Survival analysis of a prospective multicenter observational study on surgical palliation among patients receiving treatment for malignant gastric outlet obstruction caused by incurable advanced gastr	9
Brain metastases in gastroesophageal cancers—an underestimated complication	9
A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer	9
Preferred neoadjuvant therapy for gastric and gastroesophageal junction adenocarcinoma: a systematic review and network meta-analysis	8
Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry	8
IL-17A promotes Helicobacter pylori-induced gastric carcinogenesis via interactions with IL-17RC	8
Therapeutic value of splenectomy to dissect splenic hilar lymph nodes for type 4 gastric cancer involving the greater curvature, compared with other types	8
Jab1 promotes gastric cancer tumorigenesis via non-ubiquitin proteasomal degradation of p14ARF	8
Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS)	8
ADAMTS10 inhibits aggressiveness via JAK/STAT/c-MYC pathway and reprograms macrophage to create an anti-malignant microenvironment in gastric cancer	8
Negative impact of intraoperative blood loss on long-term outcome after curative gastrectomy for advanced gastric cancer: exploratory analysis of the JCOG1001 phase III trial	8
Development of the PERI-Gastric (PEritoneal Recurrence Index) and PERI-Gram (Peritoneal Recurrence Index NomoGRAM) for predicting the risk of metachronous peritoneal carcinomatosis after gastrectomy w	8
Drug-exposed cancer-associated fibroblasts facilitate gastric cancer cell progression following chemotherapy	8
Risk factors for gastric cancer in Japan in the 2010s: a large, long-term observational study	8
Neoadjuvant docetaxel, oxaliplatin and S‑1 (DOS) combination chemotherapy for patients with resectable adenocarcinoma of esophagogastric junction	8
Quality of life after laparoscopic sentinel node navigation surgery in early gastric cancer: a single-center cohort study	8
LRG1 mediated by ATF3 promotes growth and angiogenesis of gastric cancer by regulating the SRC/STAT3/VEGFA pathway	8
External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?	7
Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061	7

Reappraise role of No. 10 lymphadenectomy for proximal gastric cancer in the era of minimal invasive surgery during total gastrectomy: a pooled analysis of 4 prospective trial	7
Clinical advantage of standardized robotic total gastrectomy for gastric cancer: a single-center retrospective cohort study using propensity-score matching analysis	7
Accuracy of upper endoscopies with random biopsies to identify patients with gastric premalignant lesions who can safely be exempt from surveillance	7
Association between HER2 heterogeneity and clinical outcomes of HER2-positive gastric cancer patients treated with trastuzumab	7
Accuracy of H. pylori fecal antigen test using fecal immunochemical test (FIT)	7
Incidence and treatment outcomes of metachronous gastric cancer occurring after curative endoscopic submucosal dissection of undifferentiated-type early gastric cancer: Japan Clinical Oncology Group s	7
Pattern of lymph node metastases in gastric cancer: a side-study of the multicenter LOGICA-trial	7
The methylation level of a single cancer risk marker gene reflects methylation burden in gastric mucosa	7
Clinicopathologic and genomic characteristics of mucinous gastric adenocarcinoma	7
Prognostic value of patient-reported quality of life for survival in oesophagogastric cancer: analysis from the population-based POCOP study	7
Clinical outcomes of laparoscopic and endoscopic cooperative surgery for submucosal tumors on the esophagogastric junction: a retrospective single-center analysis	7
Insertion–deletion rate is a qualitative aspect of the tumor mutation burden associated with the clinical outcomes of gastric cancer patients treated with nivolumab	7
Achieving sequential therapy in advanced gastric cancer: the importance of appropriate patient management for the elderly and/or those with ascites	7
Adequate period of surveillance in each stage for curatively resected gastric cancer: analyzing the time and rates of recurrence	7
The clinical impact of frailty on the postoperative outcomes of patients undergoing gastrectomy for gastric cancer: a propensity-score matched database study	7
Is splenectomy for dissecting splenic hilar lymph nodes justified for scirrhous gastric cancer?	7
Nationwide evaluation of mutation-tailored treatment of gastrointestinal stromal tumors in daily clinical practice	6
Molecular classification of gastric cancer predicts survival in patients undergoing radical gastrectomy based on project HOPE	6
Geographic impact on access to care and survival for non-curative esophagogastric cancer: a population-based study	6
Application value of overlap guiding tube (OGT) in assisting overlap esophagojejunostomy during laparoscopic total gastrectomy for gastric/gastroesophageal junction (G/GEJ) tumors	6
Multiple gastrointestinal stromal tumors caused by a novel germline KIT gene mutation (Asp820Gly): a case report and literature review	6
International Delphi consensus guidelines for follow-up after prophylactic total gastrectomy: the Life after Prophylactic Total Gastrectomy (LAP-TG) study	6
Prediction of S-1 adjuvant chemotherapy benefit in Stage II/III gastric cancer treatment based on comprehensive gene expression analysis	6
Remission of type 2 diabetes after gastrectomy for gastric cancer: diabetes prediction score	6
Docetaxel plus S-1 versus cisplatin plus S-1 in unresectable gastric cancer without measurable lesions: a randomized phase II trial (HERBIS-3)	6
Open versus laparoscopic gastrectomy for advanced gastric cancer: a propensity score matching analysis of survival in a western population—on behalf of the Italian Research Group for Gastric Cancer	6
International cost-effectiveness analysis evaluating endoscopic screening for gastric cancer for populations with low and high risk	6
The combination of gene hyperamplification and PD-L1 expression as a biomarker for the clinical benefit of tislelizumab in gastric/gastroesophageal junction adenocarcinoma	5
Discrepancy between endoscopic and pathological ulcerative findings in clinical intramucosal early gastric cancer	5
Safety assessment of robotic gastrectomy and analysis of surgical learning process: a multicenter cohort study	5
Cooperation between artificial intelligence and endoscopists for diagnosing invasion depth of early gastric cancer	5
Systematic review of health-related quality of life (HRQoL) issues associated with gastric cancer: capturing cross-cultural differences	5
Synergistic effects of Rapamycin and Fluorouracil to treat a gastric tumor in a PTEN conditional deletion mouse model	5
Short- and long-term oncological outcomes of totally laparoscopic gastrectomy versus laparoscopy-assisted gastrectomy for clinical stage I gastric cancer	5
Personalized therapeutic strategies in HER2-driven gastric cancer	5
Leukaemia inhibitory factor in gastric cancer: friend or foe?	5
A deep-learning based system using multi-modal data for diagnosing gastric neoplasms in real-time (with video)	5
Risk factors and oncological impact of positive resection margins in gastrectomy for cancer: are they salvaged by an additional resection?	5
Discovery and validation of an expression signature for recurrence prediction in high-risk diffuse-type gastric cancer	5
Impact of endoscopic resection on the choice of surgical procedure in patients with additional laparoscopic gastrectomy	5
Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study	5
CD44v3 is a marker of invasive cancer stem cells driving metastasis in gastric carcinoma	5
Reply to: Letter to editor on the article “Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy”	5
LOC101929709 promotes gastric cancer progression by aiding LIN28B to stabilize c-MYC mRNA	5
Comprehensive transcriptomic profiling and mutational landscape of primary gastric linitis plastica	5
Gastric cancer exosomes contribute to the field cancerization of gastric epithelial cells surrounding gastric cancer	5
Current status of and future prospects for the treatment of unresectable or metastatic gastrointestinal stromal tumours	5
Robotic gastrectomy for gastric cancer: systematic review and future directions	5
Clinical biomarkers in adjuvant chemotherapy for gastric cancer after D2 dissection by a pooled analysis of individual patient data from large randomized controlled trials	5
Prediction of tissue origin of adenocarcinomas in the esophagogastric junction by DNA methylation	4
Adenocarcinoma of the stomach and esophagogastric junction with low DNA methylation show poor prognoses	4
Clinical relevance of PD-1 positive CD8 T-cells in gastric cancer	4
Survival trends in gastric cancer patients between 1987 and 2016: a population-based cohort study in Finland	4
Molecular alterations in gastric cancer and the surrounding intestinal metaplastic mucosa: an analysis of isolated glands	4
Survival analysis of a prospective multicenter observational study on surgical palliation among patients with malignant bowel obstruction caused by peritoneal dissemination of gastric cancer	4
Radiological criteria for selecting candidates for neoadjuvant chemotherapy for gastric cancer: an exploratory analysis from the PRODIGY study	4
Spectrum of activity of dasatinib against mutant KIT kinases associated with drug-sensitive and drug-resistant gastrointestinal stromal tumors	4
Early Gastric Cancer: identification of molecular markers able to distinguish submucosa-penetrating lesions with different prognosis	4
FAK/IL-8 axis promotes the proliferation and migration of gastric cancer cells	4
Improved survival after laparoscopic compared to open gastrectomy for advanced gastric cancer: a Swedish population-based cohort study	4
QOL assessment after palliative surgery for malignant bowel obstruction caused by peritoneal dissemination of gastric cancer: a prospective multicenter observational study	4
Deep learning predicts resistance to neoadjuvant chemotherapy for locally advanced gastric cancer: a multicenter study	4
IL-1β derived from mixed-polarized macrophages activates fibroblasts and synergistically forms a cancer-promoting microenvironment	4
The potential role of nontyphoidal salmonellosis in gastric cancer: a nationwide matched cohort study	4
Glycan expression profile of signet ring cell gastric cancer cells and potential applicability of rBC2LCN-targeted lectin drug conjugate therapy	4
Prophylactic laparoscopic total gastrectomy for gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): the first report in Asia	4
Helicobacter pylori and gastric cancer: a lysosomal protease perspective	4
Diagnostic performance in gastric cancer is higher using endocytoscopy with narrow-band imaging than using magnifying endoscopy with narrow-band imaging	4